Resolving Genotype Phenotype Discordance in Antimicrobial Resistance

38 concepts28 papers1 proposal

Imagine sequencing a pathogen’s genome, identifying a known resistance gene, and concluding with absolute certainty that the corresponding drug will fail. This sequence-to-consequence pipeline represents the core promise of modern genomic diagnostics.

However, a growing body of evidence reveals a persistent genotype-phenotype diagnostic gap. Pathogens frequently break the rules: some carry well-characterized resistance genes but remain entirely susceptible in practice, while others lack any known genetic markers yet survive lethal drug doses.

To understand why this discordance happens, we have to look beyond a static checklist of DNA markers. Resistance is not merely a binary blueprint; it is a dynamic product of genetic regulation, cellular physiology, and host-environment interactions.

Silent and Inducible Resistomes

Why does a bacterium carrying a resistance gene remain susceptible during standard laboratory screening? The answer often lies in genetic regulation. Genes are costly to express, and many remain phenotypically silent until an environmental trigger forces their activation.

In Molecular antibiotic resistance mechanisms and co-transmission of the mcr-9 and metallo-β-lactamase genes in carbapenem-resistant Enterobacter cloacae complex, Shan Jiang et al. demonstrated that the colistin resistance gene mcr-9 can remain completely dormant during standard laboratory susceptibility testing. Because the gene is phenotypically silent under default conditions, diagnostics flag the strain as safe. However, once exposed to colistin during treatment, the gene is induced, triggering active resistance in vivo.

This regulatory dependency means that genomic surveillance can easily misinterpret the clinical threat. As Kewang Hu et al. observed in Molecular characterization of NDM-1-producing carbapenem-resistant E. cloacae complex from a tertiary hospital in Chongqing, China, resistance genes frequently require specific, multi-component regulatory systems to be co-present to function. Without these activators, the DNA is inert. This is why environmental metagenomic maps, such as the hospital microbiome cartography designed by Chenhao Li et al. in Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment, can detect an abundance of antibiotic resistance genes (ARGs) without those environments necessarily yielding an equivalent incidence of functionally resistant infections.

[ Genomic DNA ] ───► Contains Resistance Gene (e.g., mcr-9)
                         │
                         ▼ (No Inducer Present)
                   [ Gene is Silent ] ───► Phenotype: SUSCEPTIBLE
                         │
                         ▼ (Exposure to Antibiotic Inducer)
                   [ Gene Expressed ] ───► Phenotype: RESISTANT

The Blind Spots of Reference Databases

The converse problem—phenotypic resistance in the absence of known resistance genes—stems from the limitations of our reference databases. Most molecular assays only look for established, widespread resistance mechanisms, such as specific enzymatic modifiers or efflux pumps. They are blind to novel mutations or structural variants that achieve the same functional outcome.

For instance, Dianpeng Han et al. in Twenty-seven-nucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus identified a novel macrolide resistance mechanism driven by a 27-nucleotide duplication in the rplV gene. This mutation alters the structure of the ribosomal protein L22, physically blocking the antibiotic from binding. Because this mechanism does not rely on traditional resistance genes, standard molecular screening tools miss it entirely, creating a dangerous diagnostic blind spot.

This limitation becomes highly visible when analyzing isolated or extreme environments. When Camilla Urbaniak et al. conducted a systematic phenotype-genotype discrepancy analysis on surfaces within the International Space Station in Detection of antimicrobial resistance genes associated with the International Space Station environmental surfaces, they repeatedly isolated organisms that survived high antibiotic concentrations despite lacking any known genetic markers. Similarly, Satomi Takei et al. showed in Identification of Mycobacterium abscessus using the peaks of ribosomal protein L29, L30 and hemophore-related protein by MALDI-MS proteotyping that using broad taxonomic or subspecies biomarkers as a proxy for resistance fails because it overlooks independent, uncharacterized point mutations that emerge downstream.

Quantitative Expression and Physiological Buffering

Genetics often treats resistance as a binary trait (present or absent), but physical survival is inherently quantitative. The presence of a gene does not dictate how much of its product is generated, nor how effectively that product interacts with the rest of the cell's physiology.

In Determining the minimum inhibitory concentrations of pyrazinamide against Mycobacterium tuberculosis clinical isolates at a neutral pH of 6.8 using the broth microdilution method, Maria Tamblin et al. demonstrated that bacterial strains possessing identical drug-activating enzymes exhibit a wide, continuous spectrum of Minimum Inhibitory Concentrations (MICs). Genetic presence alone cannot predict this variance.

As documented by Zihui Gao et al. in Investigation of antibiotic resistance genotypic and phenotypic characteristics of marine aquaculture fish carried in the Dalian area of China, this gap exists because a cell's ultimate survival depends on a complex network of physiological buffers—such as baseline membrane permeability and the expression level of non-specific efflux pumps—that modulate the intracellular drug concentration. Because of these underlying physiological variables, researchers like Gong Cheng et al. in Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023 and Huahui Zhang et al. in Analysis of the status and risk factors for Helicobacter pylori infection and drug resistance in the Lianyungang area, China maintain that molecular detection must still be validated by laboratory-based phenotypic susceptibility testing to confirm actual therapeutic boundaries.

The Clinical and Environmental Disconnect

The final, most complex layer of discordance occurs when moving from a controlled laboratory setting into a living patient. A pathogen that appears genetically and phenotypically "resistant" in a test tube may still be successfully cleared by a patient's body, and vice versa.

[ Bacterial Genotype ] ───► Dictates potential biochemical mechanisms
         │
         ▼ (Buffered by expression levels & efflux pumps)
[ In Vitro Phenotype ] ───► Dictates survival in a standardized test tube
         │
         ▼ (Overwhelmed or assisted by host immunity, lipids, & drug dose)
[ Clinical Outcome ]   ───► Determines patient recovery or treatment failure

This occurs because clinical outcomes are multifactorial. In Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia, Xiao-Wen Zhan et al. discovered that while specific genetic mutations successfully confer macrolide resistance in vitro, they do not statistically predict whether a patient will develop a refractory, unmanageable infection. Factors like the host's immune response and total bacterial load are often more decisive in determining drug efficacy than the pathogen's genetic profile alone.

Furthermore, the systemic metabolic environment of the host can alter drug dynamics. Mingming Zhang et al. demonstrated in CYP2C19 polymorphisms and lipoproteins associated with clopidogrel resistance in children with Kawasaki disease in China: A prospective study that predicting therapeutic resistance requires combining genetic data with host metabolic markers, such as lipid profiles, which independently alter drug availability.

Conversely, aggressive clinical protocols can sometimes render genetic resistance irrelevant. As Fanni Ojala et al. showed via computational modeling in Bayesian modeling of the impact of antibiotic resistance on the efficiency of MRSA decolonization, pathogens carrying genetic markers for antiseptic resistance frequently fail to survive topical hygiene protocols. In these cases, the sheer concentration of the chemical agent combined with the mechanical action of washing simply overwhelms the bacteria's genetically encoded defenses.

Harnessing Discordance for Discovery

Rather than treating genotype-phenotype discrepancies as failures of molecular biology, modern computational frameworks leverage these mismatches as a tool for discovery.

By training machine learning models on massive, paired datasets of whole-genome sequences and physical susceptibility profiles, platforms like GenTB, developed by Matthias I. Gröschel et al. in GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning, systematically isolate discordant predictions. When a model's sequence-based prediction clashes with physical lab results, it flags that specific isolate for deeper biochemical analysis.

This systematic discordance mapping allows researchers to bypass the slow process of manual gene discovery, rapidly pointing them toward hidden regulatory networks, novel point mutations, and uncharacterized resistance mechanisms that would otherwise remain lost in the diagnostic gap.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_genotype_phenotype_discordance_7b06bedc,
  title = {genotype-phenotype discordance},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/genotype-phenotype-discordance/rdr_7b06bedcf6c643a29c4b3eb2de376c7b},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}

This exact version (version 1, frozen text):

@misc{lacuna_genotype_phenotype_discordance_7b06bedc_v1,
  title = {genotype-phenotype discordance},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/genotype-phenotype-discordance/rdr_7b06bedcf6c643a29c4b3eb2de376c7b/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake